Top insider buys: Nov 13 – Nov 19, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between Nov 13 – Nov 19, 2023.

Week 46, 2023

#CompanyWho boughtSharesValueSource
1JANX

Janux Therapeutics, Inc.

2 officers/directors

Cluster buy

Tighe Reardon, Jay Lichter, Avalon Ventures XI, L.P.

1,699,708

$10.0M

+$5.0M by large holders

SEC filings
2TXO

TXO Partners, L.P.

4 officers/directors

Cluster buy

Keith A. Hutton, William H. Adams III, Bob R. Simpson, KING LUTHER CAPITAL MANAGEMENT CORP, Luther King Jr.

486,890

$8.6M

+$276K by large holders

SEC filings
3FBIO

Fortress Biotech, Inc.

2 officers/directors

Cluster buy

Lindsay A. Rosenwald Md., Michael S. Weiss

1,714,573

$2.9M

SEC filings
4TKO

TKO Group Holdings, Inc.

4 officers/directors

Cluster buy

Ariel Emanuel, Mark S. Shapiro, Carrie Wheeler, Jonathan Kraft

34,459

$2.7M

SEC filings
5GRWG

GrowGeneration Corp.

2 officers/directors

Cluster buy

Michael Salaman, Darren Lampert

926,000

$2.0M

SEC filings
6AMRC

Ameresco, Inc.

2 officers/directors

Cluster buy

George P. Sakellaris, Nicole E. Bulgarino

80,000

$1.9M

SEC filings
7RILY

B. Riley Financial, Inc.

4 officers/directors

Cluster buy

Agostino Robert P. D., Randall E. Paulson, Bryant R. Riley, Robert L. Antin

80,000

$1.8M

SEC filings
8BILL

BILL Holdings, Inc.

2 officers/directors

Cluster buy

Scott Wagner, David Hornik

26,460

$1.5M

SEC filings
9SEDG

SOLAREDGE TECHNOLOGIES, INC.

2 officers/directors

Cluster buy

Marcel Gani, More Avery

20,300

$1.5M

SEC filings
10OPK

OPKO HEALTH, INC.

2 officers/directors

Cluster buy

Phillip Md Et Al Frost, Jane Ph D. Hsiao

1,100,000

$1.4M

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.